Expanding Access to OAT Initiation: Buprenorphine/Naloxone Rapid Access in Emergency Departments
PI: Janusz Kaczorowski (Centre de recherche du CHUM, QC)
Leadership Group: Aaron Orkin (Mount Sinai Hospital, ON); Andrew Kestler (University of British Columbia, BC); Kathryn Dong (University of Alberta, AB)
The purpose of this thematic area is to enhance access to opioid agonist treatment (OAT) in emergency departments by reviewing the current landscape of this intervention, and developing educational resources to address the gaps, attitudes, knowledge, and skills of emergency physicians. *Results from activities 1-3 will be used to contribute to the development of activities 4-5.
Emergency Department Initiation of Opioid Agonist Treatment for Patients with Opioid Dependence: A Rapid Systematic Review
Given the recent interest in OAT initiation in emergency departments to address the opioid crisis in Canada, there is a need to identify and synthesize the existing literature to better understand this intervention. Undertaking this systematic review will provide critical information to audiences engaged in research, practice, and policy.
- The systematic review was published in June, 2020.
Survey of Emergency Physician’s Attitudes toward Initiating Opioid Agonist Treatment
While the opioid crisis is a complex issue, there are a number of steps emergency physicians can take to assist patients at risk, including initiating OAT in the emergency department. However, the level of comfort and willingness of emergency physicians to initiate OAT remains unclear. A survey will be administered targeting emergency physicians across British Columbia, Alberta, Ontario, and Quebec. Objectives include:
- Identify emergency physicians’ attitudes towards initiating OAT in emergency departments, identify current prescribing patterns amongst emergency physicians (i.e. frequency of prescribing buprenorphine/naloxone), identify emergency physicians’ perceived barriers and facilitators in initiating OAT, identify emergency physicians’ awareness of resources (published guidelines, accessing addictions specialist, etc.) to ensure appropriate management and provision of OAT
- Poster presented at CSAM 2019
- Buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey was published in 2021
Expanding access to OAT in emergency departments: Phone Interviews
Differing views, attitudes and accessibility of OAT have resulted in different stages of implementation across Canadian emergency departments. To support and facilitate emergency departments in their implementation process, this activity proposes to conduct phone interviews with emergency physicians across Canada who are interested in OAT implementation The phone interviews will include discussions from the preliminary results from activity 2. After all the phone interviews are complete, the results will be used to describe the current context surrounding ED OAT implementation nationally, including key recommendations for consideration and to create an implementation resource for other emergency departments interested in expanding access to OAT.
- Poster presented at CSAM 2019
- Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study was published in 2021
- Physician perspectives on reducing harm and supporting emergency department patients who use drugs was published July 2025
Implementation and evaluation of best practices checklist for patients who use opioids in emergency departments across Canada
The CAEP/CRISM team is now accepting applications from EDs that have the capacity to implement all or part of the best practices checklist, including providing evaluation data to measure the success of the checklist towards improving care for people with OUD. Approximately ten emergency departments across Canada will be selected to receive up to a maximum of $10,000 to conduct implementation and evaluation activities. Emergency departments selected to pilot the best practices checklist will be asked to provide baseline and post-implementation data on OUD services provided. Participating EDs will receive logistical support from CRISM and expert advice from the CAEP/CRISM team. We intend to involve sites at a wide variety of stages of engagement with substance use/harm reduction policy and practice, so please consider applying!
The deadline to apply is June 30, 2025, at 23H59 EST. Learn more here.